Compound News and Research

RSS

Pharmaceutical agreement involving novel obesity compound

Bristol-Myers Squibb Company and Solvay Pharmaceuticals today announced that the companies have entered into a worldwide agreement for the Solvay compound SLV319, which is currently in Phase I development with potential for use in treating obesity and other metabolic disorders.

17 May 2004

Scientists have identified a compound that halts the activity of a deadly toxin called anthrax

University of Chicago scientists have identified a compound that halts the activity of a deadly toxin called anthrax lethal factor in laboratory tests. Nature Biotechnology will publish the findings online on May 16 and in the June issue of the journal's print edition.

17 May 2004

Researcher has learned how to maximize the cancer-fighting power of broccoli

University of Illinois researcher Elizabeth Jeffery has learned how to maximize the cancer-fighting power of broccoli. It involves heating broccoli just enough to eliminate a sulfur-grabbing protein, but not enough to stop the plant from releasing an important cancer-fighting compound called sulforaphane.

15 May 2004

Vitamin discovery offers clues for cancer chemotherapy

NH-Dartmouth Medical School cancer researchers, in a fusion of biochemistry and genetics, have discovered a new vitamin in a molecular pathway central to such vital processes as gene regulation, metabolism and aging. And, they found that milk contains this nutrient.

15 May 2004

New designer steroid discovered in anonymously provided syringe

A previously unknown synthetic "designer" steroid has been identified as tetrahydrogestrinone (THG). Researchers working out of the UCLA Olympic Analytical Laboratory in Los Angeles synthesized and characterized the "New Chemical Entity", and proceeded to develop a rapid and accurate urine detection test for it.

14 May 2004

Nonalcoholic beer impart cardiovascular benefits without the negative effects of alcohol

New findings published in the May issue of Alcoholism: Clinical & Experimental Research indicate that nonalcoholic beer may also be able to impart cardiovascular benefits without the negative effects of alcohol, by inhibiting blood coagulation and platelet activation.

14 May 2004

Cardiovascular marketing budgets hit $200 Million

Pharmaceutical companies spend more to support a cardiovascular compound's development and commercialization than other therapeutic products

12 May 2004

Ingenium's acquisition of US patents may lead to drug discovery and development

Ingenium Pharmaceuticals AG has acquired outright US patents no. 5,994,075 and no. 6,015,670 from Incyte Corporation, the company announced today.

12 May 2004

Compound found in the peels of citrus fruit can potentially lower cholesterol more effectively than prescription drugs

A compound found in the peels of citrus fruit has the potential to lower cholesterol more effectively than some prescription drugs, and without side effects, according to a study by U.S. and Canadian researchers.

11 May 2004

$Trial of a drug derived from the puffer fish for treatment of refractory cancer pain$

Trial of a drug derived from the puffer fish for treatment of refractory cancer pain

Investigators involved in the pivotal clinical trial of TectinTM enrolled and dosed the first of up to 150 patients that will participate in the study. It is one of the largest Canadian clinical trials to evaluate the efficacy and safety of a drug for treatment of medically refractory cancer pain, and will take place in up to 25 treatment centres across Canada.

11 May 2004

Country Industry Forecast - European Union Healthcare Industry

The accession of ten more central and east European countries to the European Union (EU) -15 in 2004 has created a single European market, the largest market and trading zone for the healthcare industry with almost 500 million consumers. The total healthcare industry comprising pharmaceuticals and drugs, medical devices and equipment, and health services is expected to grow at a compound annual growth rate of 6.4 per cent from 2003 to 2008.

11 May 2004

Vegetables yield anticancer chemical

Plant chemicals created during the preparation of some vegetables could kill colon cancer cells in a similar way to some cancer drugs.

10 May 2004

Fresh cherries may help people who suffer from the pain of gout or other forms of arthritic inflammation

Fresh cherries may help people who suffer from the pain of gout or other forms of arthritic inflammation. That's according to preliminary results from research at the Agricultural Research Service's Western Human Nutrition Research Center in Davis, Calif.

10 May 2004

New device - the anthrax smoke detector

A new device, nicknamed "the anthrax smoke detector,' which relies on technology developed by JPL and Caltech scientists, may serve as a first line of defense against acts of bioterrorism.

6 May 2004

7 health workers face firing squad after being detained for over 5 years

A Libyan court has sentenced six Bulgarian health workers and a Palestinian doctor convicted of spreading AIDS to death by firsing squad. The seven were originally arrested in February 1999 and have since been incarcerated in an inconspicuous grey compound in Tripoli's chaotic western suburbs.

6 May 2004

Organic superglues, disease treatments and better food flavourings

Organic superglues, disease treatments and better food flavourings: these are some of the projects where synthetic organic chemist Carol Taylor employs her skills.

5 May 2004

Cymbalta helped patients with depression feel better

Patients treated successfully with 60 mg per day of the investigational antidepressant Cymbalta® (duloxetine hydrochloride), were less likely to have their emotional and physical symptoms of depression return than those who stopped taking medication after beginning to feel better

3 May 2004

New robot tackles aseptic process environments

ATS Automation Tooling Systems has announced it is showcasing a prototype of its new, ultra-clean, aseptic robot at INTERPHEX, the pharmaceutical industry's premier annual equipment exposition opening tomorrow in New York City.

30 Apr 2004

Functional genomics and proteomics may accelerate the discovery of new drugs and therapeutic molecules

Functional genomics and proteomics have been quite successful in identifying functions of potential therapeutic targets such as encoded proteins. In fact, the possibilities of identifying more than 10,000 novel target antigens in the human genome may accelerate the discovery of new drugs and therapeutic molecules.

29 Apr 2004

A burst of brain energy depends more on a unique molecular cycle than on blood flow variation

A century old mystery is taking place in your head as you read these words. Blood vessels in regions of your brain are widening, bathing cells in an increased blood flow.

28 Apr 2004